{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:14:19Z","timestamp":1793330059536,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T00:00:00Z","timestamp":1312588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10549-011-1697-6","type":"journal-article","created":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T08:43:12Z","timestamp":1312533792000},"page":"867-875","source":"Crossref","is-referenced-by-count":50,"title":["Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation"],"prefix":"10.1007","volume":"129","author":[{"given":"Emilia","family":"Montagna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bagnardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rotmensz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cancello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuelita","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Ghisini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Luini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Rafaniello","family":"Raviele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Giuseppe","family":"Mastropasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,6]]},"reference":[{"key":"1697_CR1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archsurg.1982.01380330004002","volume":"117","author":"JR Vilcoq","year":"1982","unstructured":"Vilcoq JR, Calle R, Ferme F et al (1982) Conservative treatment of axillary adenopathy due to a probable subclinical breast cancer. Arch Surg 117:1136\u20131138","journal-title":"Arch Surg"},{"key":"1697_CR2","first-page":"302","volume":"98","author":"HW Owen","year":"1954","unstructured":"Owen HW, Dockerty MB, Gray HK (1954) Occult carcinoma of the breast. Surg Gynecol Obstet 98:302\u2013308","journal-title":"Surg Gynecol Obstet"},{"key":"1697_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10549-004-9453-9","volume":"88","author":"V Galimberti","year":"2004","unstructured":"Galimberti V, Bassani G, Monti S et al (2004) Clinical experience with axillary presentation breast cancer. Br Can Res and Treat 88:43\u201347","journal-title":"Br Can Res and Treat"},{"key":"1697_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.suc.2007.01.002","volume":"87","author":"LA Newman","year":"2007","unstructured":"Newman LA, Singletary SE (2007) Overview of adjuvant systemic therapy in early stage breast cancer. Surg Clin North Am 87:499\u2013509","journal-title":"Surg Clin North Am"},{"key":"1697_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/030089167906500109","volume":"65","author":"P Vezzoni","year":"1979","unstructured":"Vezzoni P, Balestrazzi A, Bignami P et al (1979) Axillary lymph node metastases from occult carcinoma of the breast. Tumori 65:87\u201391","journal-title":"Tumori"},{"key":"1697_CR6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0046-8177(90)90008-S","volume":"21","author":"PP Rosen","year":"1990","unstructured":"Rosen PP, Kimmel M (1990) Occult breast carcinoma presenting with axillary lymph node metastases. A follow-up study of 48 patients. Hum Pathol 21:518\u2013524","journal-title":"Hum Pathol"},{"key":"1697_CR7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1097-0142(19920715)70:2<504::AID-CNCR2820700221>3.0.CO;2-T","volume":"70","author":"M Merson","year":"1992","unstructured":"Merson M, Andreola S, Galimberi V et al (1992) Breast carcinoma presenting as axillary metastases without evidence of a primary tumour. Cancer 70:504\u2013508","journal-title":"Cancer"},{"key":"1697_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02966948","volume":"2","author":"T Kyokane","year":"1995","unstructured":"Kyokane T, Akashi-Tanaka S, Matsui T et al (1995) Clinicopathological characteristics of non-palpable breast cancer presenting as an axillary mass. Breast Cancer 2:105\u2013112","journal-title":"Breast Cancer"},{"issue":"6797","key":"1697_CR9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752","journal-title":"Nature"},{"issue":"1","key":"1697_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-009-0499-6","volume":"119","author":"JJ Ronde de","year":"2010","unstructured":"de Ronde JJ, Hannemann J, Halfwerk H et al (2010) Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response. Breast Cancer Res Treat 119(1):119\u2013126","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"1697_CR11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D et al (2009) Ki67 Index, HER2 status, and prognosis of patients with Luminal B breast cancer. J Natl Cancer Inst 101(10):736\u2013750","journal-title":"J Natl Cancer Inst"},{"key":"1697_CR12","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1200\/JCO.2008.18.1024","volume":"27","author":"J Hugh","year":"2009","unstructured":"Hugh J, Hanson J, Cheang MC et al (2009) Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. J Clin Oncol 27:1168\u20131176","journal-title":"J Clin Oncol"},{"key":"1697_CR13","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/annonc\/mdq072","volume":"21","author":"G Cancello","year":"2010","unstructured":"Cancello G, Maisonneuve P, Rotmensz N et al (2010) Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35\u00a0years) with operable breast cancer. Ann Oncol 21:1974\u20131981","journal-title":"Ann Oncol"},{"issue":"18","key":"1697_CR14","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1200\/JCO.2009.25.9549","volume":"28","author":"M Colleoni","year":"2010","unstructured":"Colleoni M, Cole BF, Viale G et al (2010) Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Clin Oncol 28(18):2966\u20132973","journal-title":"J Clin Oncol"},{"key":"1697_CR15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0959-8049(99)00005-2","volume":"35","author":"M Colleoni","year":"1999","unstructured":"Colleoni M, Orvieto E, Nol\u00e8 F et al (1999) Prediction of response to primary chemotherapy for operable breast cancer. Eur J Cancer 35:574\u2013579","journal-title":"Eur J Cancer"},{"key":"1697_CR16","volume-title":"The statistical analysis of failure time data","author":"JD Kalbfleisch","year":"1980","unstructured":"Kalbfleisch JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley, San Francisco"},{"key":"1697_CR17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist 16:1141\u20131154","journal-title":"Ann Statist"},{"issue":"Suppl 1","key":"1697_CR18","first-page":"575","volume":"19","author":"E Svastics","year":"1993","unstructured":"Svastics E, Ronay P, Bodo M (1993) Occult breast cancer presenting with axillary metastasis. Eur J Surg Oncol 19 (Suppl 1):575\u2013580","journal-title":"Eur J Surg Oncol"},{"key":"1697_CR19","first-page":"431","volume":"61","author":"B Jackson","year":"1995","unstructured":"Jackson B, Scot-Conner C, Moulder J (1995) Axillary metastasis from occult breast carcinoma: diagnosis and management. Am Surg 61:431\u2013434","journal-title":"Am Surg"},{"key":"1697_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-009-0554-3","volume":"119","author":"G Pentheroudakis","year":"2010","unstructured":"Pentheroudakis G, Lazaridis G, Pavlidis N (2010) Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence. Breast Cancer Res Treat 119:1\u201311","journal-title":"Breast Cancer Res Treat"},{"key":"1697_CR21","doi-asserted-by":"crossref","unstructured":"Panoff JE, Hurley J, Takita C et al (2011) Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Treat 899\u2013906","DOI":"10.1007\/s10549-011-1495-1"},{"issue":"15 Pt 1","key":"1697_CR22","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI et al (2007) Triple negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13(15 Pt 1):4429\u20134434","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1697_CR23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/106689690501300302","volume":"13","author":"AV Bassarova","year":"2005","unstructured":"Bassarova AV, Nesland JM, Sedloev T et al (2005) Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53. Int J Surg Pathol 13(3):239\u2013240","journal-title":"Int J Surg Pathol"},{"issue":"14","key":"1697_CR24","first-page":"5345","volume":"61","author":"M Tanner","year":"2001","unstructured":"Tanner M, J\u00e4rvinen P, Isola J (2001) Amplification of HER-2\/neu and topoisomerase IIalpha in primary and metastatic breast cancer. Cancer Res 15 61(14):5345\u20135348","journal-title":"Cancer Res 15"},{"key":"1697_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jso.10243","volume":"83","author":"C Iguchi","year":"2003","unstructured":"Iguchi C, Nio Y, Itakura M et al (2003) Heterogenic expression of oestrogen receptor between the primary tumour and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome. J Surg Oncol 83:85\u201393","journal-title":"J Surg Oncol"},{"key":"1697_CR26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.1989.264","volume":"60","author":"C Kamby","year":"1989","unstructured":"Kamby C, Rasmussen BB, Kristensen B et al (1989) Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence. Br J Cancer 60:252\u2013257","journal-title":"Br J Cancer"},{"key":"1697_CR27","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/90.21.1601","volume":"90","author":"A Goldhirsch","year":"1998","unstructured":"Goldhirsch A, Glick JH, Gelber RD et al (1998) Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst 90:1601\u20131608","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1697_CR28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","volume":"20","author":"A Goldhirsch","year":"2009","unstructured":"Goldhirsch A, Ingle JN, Gleber RD et al (2009) Thresholds for therapies: highlights of the St Gallen International expert consensus on the primary therapy of early breast cancer. Ann Oncol 20(8):1319\u20131329","journal-title":"Ann Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1697-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1697-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T20:17:34Z","timestamp":1560457054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1697-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1697-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,6]]}}}